KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 150 filers reported holding KURA ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $476,028 | -20.6% | 52,196 | -7.8% | 0.06% | -21.8% |
| Q2 2023 | $599,198 | -13.5% | 56,635 | -0.0% | 0.08% | -17.9% |
| Q1 2023 | $692,817 | -1.4% | 56,649 | +0.0% | 0.10% | -7.8% |
| Q4 2022 | $702,840 | -9.2% | 56,635 | 0.0% | 0.10% | -28.0% |
| Q3 2022 | $774,000 | -25.5% | 56,635 | -0.2% | 0.14% | -45.2% |
| Q2 2022 | $1,039,000 | -98.2% | 56,724 | -93.8% | 0.26% | -66.7% |
| Q1 2022 | $56,635,000 | +7023.9% | 910,690 | +1503.0% | 0.78% | +253.2% |
| Q4 2021 | $795,000 | -25.0% | 56,813 | +0.3% | 0.22% | -25.8% |
| Q3 2021 | $1,060,000 | -10.2% | 56,635 | -0.0% | 0.30% | -23.1% |
| Q2 2021 | $1,181,000 | -19.3% | 56,656 | +9.4% | 0.39% | -27.6% |
| Q1 2021 | $1,464,000 | -19.7% | 51,792 | -7.3% | 0.54% | -19.6% |
| Q4 2020 | $1,824,000 | – | 55,869 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |